These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 19457162)
21. Mapping and kinetics of microglia/neuron cell-to-cell contacts in the 6-OHDA murine model of Parkinson's disease. Virgone-Carlotta A; Uhlrich J; Akram MN; Ressnikoff D; Chrétien F; Domenget C; Gherardi R; Despars G; Jurdic P; Honnorat J; Nataf S; Touret M Glia; 2013 Oct; 61(10):1645-58. PubMed ID: 23893349 [TBL] [Abstract][Full Text] [Related]
22. Dopamine D2 receptor knockout mice develop features of Parkinson disease. Tinsley RB; Bye CR; Parish CL; Tziotis-Vais A; George S; Culvenor JG; Li QX; Masters CL; Finkelstein DI; Horne MK Ann Neurol; 2009 Oct; 66(4):472-84. PubMed ID: 19847912 [TBL] [Abstract][Full Text] [Related]
23. Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death. Jiang H; Wu YC; Nakamura M; Liang Y; Tanaka Y; Holmes S; Dawson VL; Dawson TM; Ross CA; Smith WW Neurobiol Aging; 2007 Nov; 28(11):1709-17. PubMed ID: 16978743 [TBL] [Abstract][Full Text] [Related]
24. [Role of microglial activation induced by α-synuclein in pathogenesis of Parkinson's disease]. Qiao S; Luo JH; Jin JH Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 41(2):210-4. PubMed ID: 22499522 [TBL] [Abstract][Full Text] [Related]
25. MT1-MMP: a key regulator of cell migration in tissue. Itoh Y IUBMB Life; 2006 Oct; 58(10):589-96. PubMed ID: 17050376 [TBL] [Abstract][Full Text] [Related]
26. CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson's disease. Li Y; Niu M; Zhao A; Kang W; Chen Z; Luo N; Zhou L; Zhu X; Lu L; Liu J J Neuroinflammation; 2019 Dec; 16(1):263. PubMed ID: 31831012 [TBL] [Abstract][Full Text] [Related]
27. Long-term polarization of microglia upon α-synuclein overexpression in nonhuman primates. Barkholt P; Sanchez-Guajardo V; Kirik D; Romero-Ramos M Neuroscience; 2012 Apr; 208():85-96. PubMed ID: 22342967 [TBL] [Abstract][Full Text] [Related]
28. Neuron-microglia crosstalk up-regulates neuronal FGF-2 expression which mediates neuroprotection against excitotoxicity via JNK1/2. Figueiredo C; Pais TF; Gomes JR; Chatterjee S J Neurochem; 2008 Oct; 107(1):73-85. PubMed ID: 18643872 [TBL] [Abstract][Full Text] [Related]
29. Alpha-synuclein and Parkinson's disease: a proteomic view. Fasano M; Lopiano L Expert Rev Proteomics; 2008 Apr; 5(2):239-48. PubMed ID: 18466054 [TBL] [Abstract][Full Text] [Related]
30. Effects of human marrow stromal cells on activation of microglial cells and production of inflammatory factors induced by lipopolysaccharide. Zhou C; Zhang C; Chi S; Xu Y; Teng J; Wang H; Song Y; Zhao R Brain Res; 2009 May; 1269():23-30. PubMed ID: 19269277 [TBL] [Abstract][Full Text] [Related]
31. Neuroprotective effects of the anti-inflammatory compound triflusal on ischemia-like neurodegeneration in mouse hippocampal slice cultures occur independent of microglia. Montero Domínguez M; González B; Zimmer J Exp Neurol; 2009 Jul; 218(1):11-23. PubMed ID: 19341733 [TBL] [Abstract][Full Text] [Related]
32. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder? Rogers J; Mastroeni D; Leonard B; Joyce J; Grover A Int Rev Neurobiol; 2007; 82():235-46. PubMed ID: 17678964 [TBL] [Abstract][Full Text] [Related]
33. Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease. Marinova-Mutafchieva L; Sadeghian M; Broom L; Davis JB; Medhurst AD; Dexter DT J Neurochem; 2009 Aug; 110(3):966-75. PubMed ID: 19549006 [TBL] [Abstract][Full Text] [Related]
34. Abnormal production of macrophage inflammatory protein-1alpha by microglial cell lines derived from neonatal brains of Sandhoff disease model mice. Kawashita E; Tsuji D; Kawashima N; Nakayama K; Matsuno H; Itoh K J Neurochem; 2009 Jun; 109(5):1215-24. PubMed ID: 19302485 [TBL] [Abstract][Full Text] [Related]
35. Controlling the mass action of alpha-synuclein in Parkinson's disease. Kim C; Lee SJ J Neurochem; 2008 Oct; 107(2):303-16. PubMed ID: 18691382 [TBL] [Abstract][Full Text] [Related]
36. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides. Gallardo G; Schlüter OM; Südhof TC Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066 [TBL] [Abstract][Full Text] [Related]
37. Hyaluronan-CD44 interaction stimulates Rac1 signaling and PKN gamma kinase activation leading to cytoskeleton function and cell migration in astrocytes. Bourguignon LY; Gilad E; Peyrollier K; Brightman A; Swanson RA J Neurochem; 2007 May; 101(4):1002-17. PubMed ID: 17403031 [TBL] [Abstract][Full Text] [Related]
38. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease. Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873 [TBL] [Abstract][Full Text] [Related]
39. Decreased alpha-synuclein expression in the aging mouse substantia nigra. Mak SK; McCormack AL; Langston JW; Kordower JH; Di Monte DA Exp Neurol; 2009 Dec; 220(2):359-65. PubMed ID: 19800328 [TBL] [Abstract][Full Text] [Related]
40. Exosomes of BV-2 cells induced by alpha-synuclein: important mediator of neurodegeneration in PD. Chang C; Lang H; Geng N; Wang J; Li N; Wang X Neurosci Lett; 2013 Aug; 548():190-5. PubMed ID: 23792198 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]